Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Chimeric Therapeutics - Preliminary Final Report (ASX:CHM)

Distributions No dividends have been paid or declared by the company for the current financial period. No dividends were paid for the previous financial period. Explanation of results The g...read more

Chimeric Therapeutics Appoints Jennifer Chow as CEO & MD (ASX:CHM)

Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), a clinical-stage cell therapy company, is pleased to announce the appointment of current Chief Operating Officer...read more

Carbonxt Group - Appendix 4G and Corporate Governance Statement (ASX:CG1)

To view the appendix, download the attached PDF.

Carbonxt Group - Annual Report and Appendix 4E (ASX:CG1)

To view the Preliminary final report, download the attached PDF.

Carbonxt Group - FY21 Results (ASX:CG1)

The Company’s Activated Carbon Pellet business segment continued to show strong market penetration, where revenue growth outside of its largest pellet customer was 118% compared to FY20. This...read more

Viewing: 196 - 210 of 200 Previous | Next